LOOOL.... thanks Kasra jan. You have a lot of lotf to me.
Oh, if you use anti-CD20 for treatment of lymphoma, you are depleting B cells. I guess your patients have some kind of a B cell lymphoma. But is that specific? because a normal CD20 inhibitor will also deplete healthy B cells.
But anyways, wow... I'm very impressed by your merits! Internal medicine, Oncology and Rheumatology! How did you have the time (talking about enthusiastic and smart)?? Are you still at Yale university or do you work else where now?
Kasra jan, I have an MS in biotech engineering and now I do research at Karolinska Institutet in Sweden. I work with immune response in cancer patients with solid tumors (all kinds, colon cancer, urinary bladder cancer, prostate cancer, pancreatic cancer, melanoma and even penis cancer, and more...). More specifically I work with B cells as APCs (antigen presenting cells) in these patients. My research goes back to an adoptive immunotherapy background where the patients' own tumor specific T cells are expanded and retransfused in the patients' body.
As for laboratory medicine..... I don't know if there is much money in that either. I think I should do a Bijans (an old member in this forum) and go into restaurant business.
Oh, if you use anti-CD20 for treatment of lymphoma, you are depleting B cells. I guess your patients have some kind of a B cell lymphoma. But is that specific? because a normal CD20 inhibitor will also deplete healthy B cells.
But anyways, wow... I'm very impressed by your merits! Internal medicine, Oncology and Rheumatology! How did you have the time (talking about enthusiastic and smart)?? Are you still at Yale university or do you work else where now?
Kasra jan, I have an MS in biotech engineering and now I do research at Karolinska Institutet in Sweden. I work with immune response in cancer patients with solid tumors (all kinds, colon cancer, urinary bladder cancer, prostate cancer, pancreatic cancer, melanoma and even penis cancer, and more...). More specifically I work with B cells as APCs (antigen presenting cells) in these patients. My research goes back to an adoptive immunotherapy background where the patients' own tumor specific T cells are expanded and retransfused in the patients' body.
As for laboratory medicine..... I don't know if there is much money in that either. I think I should do a Bijans (an old member in this forum) and go into restaurant business.
Last edited: